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Abstract
Background: Novel therapeutics are urgently needed to control tuberculosis (TB). Thioridazine (THZ) is a candidate for the
therapy of multidrug and extensively drug-resistant TB.
Methodology/Principal Findings: We studied the impact of THZ on Mycobacterium tuberculosis (Mtb) by analyzing gene
expression profiles after treatment at the minimal inhibitory (1x MIC) or highly inhibitory (4x MIC) concentrations between
1–6 hours. THZ modulated the expression of genes encoding membrane proteins, efflux pumps, oxido-reductases and
enzymes involved in fatty acid metabolism and aerobic respiration. The Rv3160c-Rv3161c operon, a multi-drug transporter
and the Rv3614c/3615c/3616c regulon, were highly induced in response to THZ. A significantly high number of Mtb genes
co-expressed with s
B (the s
B regulon) was turned on by THZ treatment. s
B has recently been shown to protect Mtb from
envelope-damage. We hypothesized that THZ damages the Mtb cell-envelope, turning on the expression of the s
B regulon.
Consistent with this hypothesis, we present electron-microscopy data which shows that THZ modulates cell-envelope
integrity. Moreover, the Mtb mutants in s
H and s
E, two alternate stress response sigma factors that induce the expression of
s
B, exhibited higher sensitivity to THZ, indicating that the presence and expression of s
B allows Mtb to resist the impact of
THZ. Conditional induction of s
B levels increased the survival of Mtb in the presence of THZ.
Conclusions/Significance: THZ targets different pathways and can thus be used as a multi-target inhibitor itself as well as
provide strategies for multi-target drug development for combination chemotherapy. Our results show that the Mtb sigma
factor network comprising of s
H, s
E and s
B plays a crucial role in protecting the pathogen against cell-envelope damage.
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Introduction
Tuberculosis (TB) is caused by Mtb, one of the most successful
pathogens of humanity. It leads to the death of about 1.8 million
humans annually. The emergence of multidrug resistant (MDR)
strains of Mtb, synergy between TB and AIDS and the lack of
effective vaccines and chemotherapeutics has exacerbated the
situation [1]. A major problem for the control of TB is the
requirement of drug regimens for six to nine months. These lengthy
regimens lead to non-compliance with therapy, relapse and
development of drug-resistance. In order to shorten the duration
of therapy, novel drugs that are active against Mtb, which act
through mechanisms different from those employed by the existing
frontline and secondary anti-TB drugs are urgently needed. The
‘‘non-antibiotics’’ class of compounds [2], which act by either
enhancing antibiotic activity [3–5] or reversal of antibiotic
resistance [6–9], or by induction and control of efflux pumps
[10], have the potential to act as the next generation of anti-TB
drugs. In fact, the use of the anti-psychotic phenothiazine,
thioridazine (THZ) for therapy of multidrug and extensively drug-
resistant tuberculosis infections is now being seriously considered
[11–13].THZhasbroad-spectrumantibacterialactivityagainstMtb
[5,13]. It appears to be equally active on starved Mtb, which
represents the persistent state of the pathogen, as it is during log
phase growth. This is not the case for frontline anti-TB drugs
rifampin (RIF) or isoniazid (INH), which have little or no activity
respectively, on starved cells [14]. Synergistic activity at the MIC
level between rifampicin (RIF) and streptomycin (STR), but not
INH, and the phenothiazines has been reported [5]. MICs for
phenothiazines are much higher than the corresponding values in
macrophages, since THZ concentrates inside these host cells [15].
The MICs in macrophages for inhibiting Mtb growth have been
reported as 0.23–3.6 mg/ml [10] and 0.1 mg/ml [15]. Equally
significant is the fact that at these concentrations, there were no
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demonstrated that novel phenothiazine derivatives inhibited Mtb in
the non-replicating state at MICs that were lower than those under
actively growing conditions as a ‘macrophage modulator’
[15,17,18]. THZ significantly reduced the number of colony
forming units (CFU) retrieved from the lungs of mice infected with
Mtb (10
6 CFU/ml, i.p.)withinone month at a daily dose of 0.5 mg/
day [19]. Phenothiazines in general and THZ in particular, exert
their anti-TB effects via calmodulin [20,21] or by inhibiting
NADH2-menaquinoneoxidoreductase (Ndh2) [22–24].
Mtbrespondstochangesinitsenvironmentbyalteringthelevelof
expression of critical genes that transduce such signals into
metabolic changes favoring continued growth and survival. Sigma
(s) factors are a class of transcription factors which control bacterial
gene-expression [25]. Typically most eubacteria encode a principal
sigma factor and a variable number of alternate sigma factors,
which control responses to specific environmental stimuli and
adaptation to stress [26]. The temporal expression of specific
regulons controlled by one or more alternate sigma factors likely
allows Mtb to survive in multiple phases of TB [27]. Mtb sigma
factors s
H, s
E and s
B are well studied. The expression of the latter
can be triggered by either s
H or s
E [28–30]. Thus, there exists a
network of these three factors- s
H, s
E and s
B, with overlapping
functions. s
H is induced after heat, redox, nitrosative and acid stress
[28,29,31], and phagocytosis [32,33]. s
H directly regulates the
transcription of 31 genes, including thes
E, s
B, groEL/ES and the
thioredoxin regulons [28]. s
E is also induced upon uptake by
macrophages [32], and upon treatment with hydrogen-peroxide
[34], and SDS [35]. s
E regulates the expression of at least 23 genes,
including s
B, hsp and htpX. s
E is transcribed in either a s
H [28,29]
or an MprAB-dependent [36] manner. s
B is the minor principal
sigma factor of Mtb and appears to play a key role in defense against
cell-envelope damage [37]. The expression of these sigma factors is
also altered by treatment with various anti-bacterial compounds
[38],indicatingthatthissigma-factornetwork playsa role indefense
against these anti-Mtb mechanisms.
System-wide screens can help predict specific pathways and
targets that individual anti-bacterial compounds interact with. In
turn, this has the potential to identify newer druggable target
genes, pathways and networks. Identification of clusters of
coordinately regulated genes for drug mechanism of action is a
rational approach to the selection of critical drug targets. We
conducted an in-depth investigation on the mechanism of action of
THZ by exploring drug specific changes. Some of these changes
may reflect the mode of action of THZ. Treatment with THZ
caused damage to the Mtb cell-envelope and altered its energy
metabolism. Our results show that the Mtb s
H/s
E/s
B network is
perturbed by treatment with THZ, and plays an important role in
the survival of the pathogen under such adverse conditions.
Methods
Bacterial culture and drug treatment
THZ (Sigma), dissolved in water, at a final concentration of
1xMIC (10 mg/ml) or 4xMIC (40 mg/ml) was added to Mtb
(CDC1551) cultures grown in Middlebrook 7H9-albumin-dex-
trose-catalase-Tween 80-glycerol broth at an OD546 of 0.5 - 0.6
and the cultures were aerated by shaking at 37uC for additional 1–
6 h. Control (untreated) samples were treated with the appropriate
solvent vehicle.
RNA extraction, cDNA labeling and Microarrays
In order to profile transcriptome-wide changes in response to
THZ treatment, Mtb cultures were actively cultured to log-phase,
prior to addition of the drug. RNA was isolated using the Trizol-
beadbeater method [30]. Mtb whole genome DNA microarrays
comprised of 70mer probes representing 4,269 Mtb (H37Rv and
CDC1551) genes, plus 26 controls were obtained from ‘‘TB
Vaccine Testing and Research Materials’’ Contract, Colorado
State University. Experiments were performed according to the
standard protocols disseminated by the Mycobacteria Research
Lab at the Colorado State University (http://www.cvmbs.
colostate.edu/mip/tb/pdf/arrays.pdf). Data was analyzed using
S
+ scripts within Spotfire DecisionSite for Microarray Analysis
(TIBCO-Spotfire) to determine significant expression changes,
adjusting for intensity bias using Locally Weighted Scatter-plot
Smoothing (LOWESS) normalization [30]. Genes whose expres-
sion was altered in magnitude by at least 75% in each of the two
biological replicate arrays, relative to untreated control in a
statistically significant manner (one way analysis of variance,
P#0.05) were included in our analysis.
Public access to microarray data
Our microarray experiments and data analysis were conducted
strictly in a MIAME compliant manner, per the suggestions of the
MGED society (http://www.mged.org/Workgroups/MIAME/
miame.html). Our raw and normalized microarray data is
publically available at the Gene Expression Omnibus (GEO)
database (accession number GSE16626).
Verification of microarray data by quantitative real-time
RT-PCR
RT-PCR (Applied Biosystems ABI 7700) was performed with
cDNA corresponding to 50 ng of each independent RNA sample,
using the SYBR green Supermix kit (Applied Biosystems) with
specific primers for each target (Table S1). Relative expression
levels were normalized using s
A as an invariant transcript, and
data was analyzed using the DDCt method as previously described
[30]. The average relative expression levels and the standard
deviations were determined for three independent experiments.
Analysis of the effect of THZ on Mtb cell-envelope by
electron microscopy
Log-phase cultures of unexposed Mtb CDC 1551 (untreated
control) and following incubation for 6 hr and 24 hr with 1x
MIC/4x MIC of THZ, respectively were fixed overnight in 1.25%
glutaraldehyde-2% formaldehyde in 0.1 M sodium cacodylate,
pH 7.3. They were washed in 2 changes of 0.1 M sodium
cacodylate, pH 7.3, passed through an ethanol dehydration
process, infiltrated with Epon Araldite resin, and polymerized
overnight at 70uC. Sections were cut on a MTXL ultratome
(RMC Products), placed on 150-mesh copper grids, stained with
5% uranyl acetate and lead citrate, and examined with a Zeiss 10
transmission electron microscope [39].
Comparison of the viability of Mtb, its isogenic D–s
H and
D–s
E mutants and the strain conditionally over-
expressing s
B, in the presence of THZ
A portion of recently frozen stocks of Mtb CDC1551 [40], the
isogenic Mtb CDC1551 D–s
H mutant, the isogenic Mtb CDC1551
D–s
E mutant and the Mtb CDC1551 s
B Knock-In (KI) strain [41]
were inoculated into 5 ml of Middlebrook 7H9 broth (7H9)
supplemented with 10% albumin dextrose catalase, v/v, and
0.05% Tween-80, v/v (Sigma), and incubated at 37uC for 5 days.
The induction of s
B in the s
B (KI) strain was performed as
described [41]. Briefly, the culture was grown to mid-log phase,
and acetamide was added to a final concentration of 0.2%. The
Mtb Response to Thioridazine
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incubated at 37uC with 50 rpm shaking until growth reached log
phase. Mtb CDC1551 is susceptible to THZ (MIC: 10 mg/ml,
MBC: 40 mg/ml). THZ was added to the culture at final
concentrations of 0.1x, 1xMIC, 4xMIC, and the cultures were
then incubated at 37uC up to 7 days. Control (untreated) samples
were treated with the appropriate solvent vehicle.
NADH/NAD
+ measurement
This assay was adapted from Boshoff et al. [22]. Briefly, Mtb
CDC1551 and s
B over-expressing (KI) cultures were grown to an
A650 of 0.3 and treated with THZ (10 mg/ml) for 3 h. Cells were
rapidly harvested and pellets were suspended in either acid (0.2 M
HCl) or base (0.2 M NaOH) for NAD or NADH, respectively.
Nucleotide extraction and nucleotide cycling assay were per-
formed as previously described [42]. Data represent the average of
3 independent experiments.
Results
Global transcriptional response of Mtb to THZ treatment
The Mtb CDC1551 strain [43] is sensitive [44] to THZ (MIC:
10 mg/ml) [5,13]. The drug showed noteworthy inhibitory action
(MIC90=10mg/ml) against this strain, demonstrated cidal
(minimum bactericidal concentration =40 mg/ml) activity. While
the transcriptional response of Mtb to a concentration15 mg/ml of
THZ has been reported [23], we performed an in-depth study of
the entire Mtb transcriptome to two concentrations, 1x MIC (basal
level) and 4x MIC (high level) of THZ during a number of early
time points (0–6 h post-treatment). The time points were chosen
based on published data [5,18,22,45]. Our experiment was
designed to ensure that the primary effects of the drugs and any
dose responses would be captured.
Treatment with THZ had an immediate and profound effect on
the global transcription in Mtb (Table S2 and Figure S1). Venn-
diagrams show an overlap in the Mtb gene-expression program at
different time-points (Figure S2). A total of 10 genes (Rv1057,
Rv1497, Rv2483c, Rv2710 (s
B), Rv2711, Rv2744c, Rv2745c,
Rv3065 (emrE), Rv3160c and Rv3161c) were commonly induced
at all time-points upon 1x THZ treatment (Table 1). The
expression of a total of 19 genes (Rv0251c, Rv1040c, Rv1057,
Rv1403c, Rv1404, Rv1461, Rv1463, Rv1466, Rv1497, Rv1854c,
Rv2053c, Rv2694c, Rv2710 (s
B), Rv2743c, Rv2745c, Rv3065
(emrE), Rv3160c, Rv3161c and Rv3162c) was induced after
exposure of THZ at 4XMIC. Thus, Rv1057, Rv1497, Rv2710
(s
B), Rv2745c, Rv3065, Rv3160c and Rv3161c were induced at
all time-points and in response to both 1x and 4x THZ (Table 1).
Impact of THZ on the transcription of specific Mtb
networks
The expression of the predicted Rv3160c/Rv3161c operon was
induced at all time-points, and at both concentrations, following
THZ treatment. The former encodes a TetR family member
transcription factor, while the latter encodes for a dioxygenase.
This operon is also induced in response to the anti-mycobacterials
Triclosan [22,46] and SRI967 and SRI9190 [47].
Treatment with THZ also caused a profound increase in the
expression of the Rv3065 encoded EmrE( Mmr) multidrugs
transport membrane protein. While the expression of only the
emrE gene was induced at the 1 hr (both 1x and 4x concentrations),
the expression of an entire genomic locus containing this gene,
Rv3060c-Rv3064c; Rv3065-Rv3067 was induced at 4 and 6 hr
time-points. This region includes a putative DeoR family
transcription factor encoded by the Rv3066 gene, and a gene
belonging to the carbon-starvation induced protein family,
encoded by then Rv3063 gene. Another key gene that was
induced following THZ treatment at the 1 hr time point is kgtP,
which encodes the major facilitator super-family protein. Paralogs
of this protein are involved in nitrate uptake and nitrite efflux.
At later time-points, we observed the induction of whi family
members and kas operon, also known to be induced in a s
B-
dependent manner. At 4 and 6 hrs post-THZ treatment we
observed a significant induction of ESAT-6 and the Rv3614c-
Rv3615c-Rv3616c operon, which forms the Esx-1 secretion
apparatus critical for the virulence of Mtb via both the export of
Esx virulence substrates as well as a major source of potent
immunostimulatory antigens [48]. The expression of Rv1057 and
lipL genes was also induced upon treatment with THZ.
Phenothiazines are potent inhibitors of the type II NADH-
ubiquinone dehydrogenase, as well as the membrane-bound
succinate dehydrogenase [23]. THZ blocks NADH-dependent
O2 consumption by Mtb membrane [22–24], thereby affecting
respiratory and other intermediary metabolic activities of the cell.
Consistent with this, we observed the over-expression of ndh at all
time points of 4xMIC treatment. This corroborates the work of
Boshoff et al [22]. The expression of several other genes involved
in energy metabolism, e.g. NADH dehydrogenases (nuoE, nuoF and
nuoG), isocitrate dehydrogenase (icd1), NAD-dependent malate
reductase (mez) and NADPH:quinone oxidoreductase (Rv0149)
was also induced by THZ.
The expression of fewer genes was repressed in Mtb following
THZ treatment (Table 1). Overall, four genes (fadD22, mce4, rpfE
and Rv3920c) exhibited a lower level of expression at all four time-
points (1–6 hr) following 4x MIC treatment with THZ. The
expression of a related gene, also encoding another resuscitation
promotion factor, rpfC, was repressed upon treatment with 1x
MIC THZ, although given the extensive sequence similarity
between the rpf gene family members, cross-hybridization during
microarray experiments can’t be ruled out.
Functional categorization of the post-THZ treatment
transcriptome changes in Mtb
We analyzed the effect of THZ on Mtb gene-expression based
on the basis of the various functional categories, to which the
various Mtb genes belong. The actual number of genes from each
functional category that were perturbed was compared to the
expected number for the data of a finite size. The expression of
fewer than expected genes belonging to the functional category
‘‘Intermediary metabolism’’ and a larger than expected number of
genes belonging to the categories ‘‘Transcriptional regulators’’ and
‘‘Conserved hypothetical proteins’’ was induced by THZ treat-
ment (Figure 1A). Differences were also observed in a concentra-
tion-dependent manner. Mining of the transcriptome data in the
context of functional categories yielded particularly interesting
data when applied to genes whose expression was repressed in Mtb
following THZ treatment (Figure 1B). The expression of a much
larger than anticipated number of genes belonging to the
‘‘Information pathways’’ and ‘‘Lipid metabolism’’ categories were
repressed at 2 hr post-THZ treatment. These results indicate that
in response to THZ treatment, a significant lowering of the
expression of genes belonging to many key biosynthetic pathways
is observed. Together, these results indicate that THZ treatment
causes an immediate spike in the expression of specific
transcriptional regulators that mediate the pathogen’s response
to cell-membrane damage, coupled with a silencing in expensive
energetic processes such as lipid-metabolism, and DNA, RNA and
protein synthesis. One such transcription factor is s
B, which has
recently been shown to protect Mtb against membrane damaging
Mtb Response to Thioridazine
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Condition Rv number Gene* Description
Functional
Category Fold induction (p value) [qRT-PCR]
1h 2h 4h 6h
IXMIC up
regulation
Rv1057 Conserved hypothetical 10 3.69(0.01) 9.79(0.004) 9.4(0.005) 1(0.003)
Rv1497 lipL Probable esterase LIPL 3 2.154(0.01) 3.21(0.01) 6.4(0.002) 4(0.008)
Rv2483c plsC Possible transmembrane phospholipid 1 2.292(0.01) 1.94(0.04) 3.3(0.0021) 4.3(0.01)
Rv2710 sigB Sigma Factor B 2 2.449(0.01)[2.11] 3.98(0.004)[9.27] 5(0.01) [1.02] 7(0.01) [1.47]
Rv2711 ideR Iron-dependent repressor and
activator ider
9 1.832(0.02) 1.95(0.03) 2.3(0.009) 2.9(0.006)
Rv2744c Conserved 35 KDA alanine rich protein 10 2.17(0.03) 2.26(0.03) 9.1(0.003) 5.4(0.007)
Rv2745c Possible transcriptional regulatory protein 9 2.02(0.04) [1.31] 3.32(0.01) [5.24] 35(0.001) [3.27] 8(0.005) [19.09]
Rv3065 emrE Multidrug-transport integral membrane
protein MMR
3 10.81(0.0009)
[4.86]
1.88(0.001)
[2.27]
23(0.0004)
[41.22]
31(0.0002)
[6.04]
Rv3160c Transcriptional regulatory protein 9 10.95(0.0039)
[11.26]
8.39(0.006) 19(0.0006) 39(0.001)
Rv3161c Possible dioxygenase 7 76.8(4.70E-05)
[41.65]
15.6(0.008) 38(1.85E-05) 74(0.0005)
4XMIC up
regulation
Rv0251c hsp Hypothetical exported protein 3 10.82(0.0005)
[2.93]
17(0.0009)
[3.58]
29(0.0003)
[5.90]
36(0.04)
[7.53]
Rv1040c PE family protein 6 1.983(0.04) 4.49(2.44E-06) 2.4(0.007) 2.3(0.0004)
Rv1057 Conserved hypothetical protein 10 9.5(0.003) 12.7(0.002) 8.3(0.01) 7.9(0.003)
Rv1403c Putative methyltransferase 7 1.73(0.04) 6.41(0.002) 7(0.0004) 3.8(0.002)
Rv1404 Probable transcriptional regulatory protein 9 2.53(0.02) 2.82(0.01) 3.7(0.01) 3.1(0.01)
Rv1461 Conserved hypothetical protein 10 2.98(0.01) 4.98(0.01) 7.8(0.002) 5.6(0.003)
Rv1463 Probable conserved ATP-binding protein 3 2.92(0.01653) 4.83(0.004) 5.4(0.01) 3.9(0.01)
4XMIC up
regulation
Rv1466 Conserved hypothetical protein 10 2.97(0.04) 3.91(0.01) 5.7(0.01) 4.2(0.01)
Rv1497 lipL Probable esterase LIPL 3 5.02(0.01) 5.59(0.007) 2.8(0.01) 2.6(0.01)
Rv1854c ndh Probable NADH dehydrogenase NDH 7 3.94(0.004) 2.12(0.01) 3.3(0.01) 2.1(0.01)
Rv2053c Probable transmembrane protein 3 10.19(0.001) 4.32(0.01) 2(0.0008) 2.8(0.04)
Rv2694c Conserved hypothetical protein 10 3.04(0.01) 4.69(0.009) 3.1(0.02) 3.2(0.004)
Rv2710 sigB RNA polymerase sigma factor SIGB 2 10.34(0.004)
[17.61]
14.2(0.01)
[12.32]
9.5(0.0006)
[10.73]
5.7(0.0009)
[12.60]
Rv2743c possible conserved transmembrane
alanine rich protein
3 3.74(0.01) 3.3(0.01) 3(0.02) 4(0.03)
Rv2745c Possible transcriptional regulatory protein 9 5.16(0.01)
[3.43]
5.83(0.02)
[11.33]
146(0.001)
[13.27]
10(0.005)
[89.55]
Rv3065 emrE Multidrugs-transport integral membrane
protein MMR
3 24.66(0.001)
[15.44]
24(0.0006)
[5.20]
32(0.01)
[26.40]
59(0.003)
[100.60]
Rv3160c Possible transcriptional regulatory protein 9 66.98(0.001)
[26.56]
31.4(0.0005) 23(0.0008) 21(0.0005)
Rv3161c Possible dioxygenase 7 237.3(0.01)
[155.54]
28.8(0.02) 48(0.0003) 56(0.003)
Rv3162c Possible integral membrane protein 3 2 (0.04) 4.3(0.009) 2.9(0.04) 4(0.01)
4XMIC down
regulation
Rv2950c fadD29 Probable FATTY-ACID-CoA ligase FADD29 1 24.39(0.01) 212.33(0.001) 23.92(0.008) 22.30(0.02)
Rv0170 mceD MCE-family protein MCE1B 0 27.73(0.003) 23.15(0.001) 22.05(0.005) 22.39(0.003)
Rv2450c rpfE Probable resuscitation-promoting factor RPFE 3 21.87(0.001) 27.19(0.0001) 23.76(0.001) 23.55(5.05E-05)
Rv3920c Hypothetical protein similar to JAG protein 10 21.69(0.009) 22.77(0.003) 22.94(0.01) 23.07(0.002)
Genes are annotated as described by the Pasteur Institute on TubercuList (http://genolist.pasteur.fr/TubercuList).
Enclosed genes found to be induced under both Ix and 4x MIC conditions are in bold.
Values in square brackets represent the fold induction obtained by qRT-PCR.
doi:10.1371/journal.pone.0010069.t001
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treatments with THZ. Therefore, we decided to study the role
played by this transcription factor, in defense against THZ-stress,
in detail.
Impact of THZ on the s
B regulon
A large gene-expression network that was immediately induced
following THZ treatment is controlled by the sigma factor s
B,
which is known to interact in a complex manner with other
alternate, extracytoplasmic signal induced sigma factors and
transcriptional activators/repressors [28,29,41,49]. Apart from
s
B (Rv2710), we also observed the induction of ideR (Rv2711), the
iron-dependent repressor of siderophore and mycobactin biosyn-
thesis, and hsp which codes for a heat shock protein. These genes
have previously been shown to be dependent on s
B for their
induction [41]. The htpX and clpB genes were also co-expressed
with s
B. These genes have previously been observed to be co-
expressed with s
B in other experiments where key alternate Mtb
sigma factors s
H or s
E were induced [28,30]. The expression of
Rv2745c and its adjoining genes (Rv2744c and Rv2743c) was also
significantly induced at almost all time-points. Rv2745c is known
to be induced in s
H and s
E dependent manner following
disulphide or membrane damage stress [30,37].
Since a large number of the s
B dependent genes appeared to be
induced in Mtb upon THZ treatment, we decided to analyze the
expression of the entire s
B regulon. Using either the Tuberculosis
Database (TBDB) or the NIAID BioHealthBase BRC online tool
(http://www.biohealthbase.org), we identified 100 Mtb genes that
have been classified as members of the s
B regulon and which have
an extremely high degree of co-expression correlation (0.78601 to
0.40569) with s
B. As shown in Table S3A, 89 out of these 100 s
B
co-expressed genes were induced by THZ treatment of Mtb, at any
of the several time points in our experiment, while only 11 out of
100 members of the ‘‘s
B regulon’’ were not induced by THZ. This
clearly indicates that the entire s
B regulon is turned on by THZ
treatment. Recently, Fontan et al [37] performed an in depth
study into the function of s
B in stress response. They studied s
B
regulated genes separately during stress with SDS, which induces
the expression of s
B via s
E [29], and during stress with diamide,
which induces the expression of s
B via s
H [30]. We compared our
Figure 1. Functional categorization of the global induction (A) or repression (B) in Mtb gene-expression following 1x (top panel in
both A and B) or 4x THZ (bottom panel in both A and B) treatment is shown as a series of pie charts. The first (leftmost) pie corresponds
to an expected distribution of the various functional categories into which the Mtb genes are represented based on the total number of genes
corresponding to each category. The number of genes from each functional category, whose expression was perturbed in individual THZ treatment
experiments, is represented in the subsequent pies. The first functional category (0=Virulence and detoxification) begins at 12 O Clock in very pie
and the subsequent categories are represented in a clock-wise direction.
doi:10.1371/journal.pone.0010069.g001
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S3B, 57 members of the ‘‘s
B regulon’’ out of 73 that were induced
in Mtb relative to the D–s
B mutant by SDS were also induced by
THZ treatment. Similarly, 30 members of the ‘‘s
B regulon’’ out of
41 that were induced in Mtb relative to the D–s
B mutant by SDS
were also induced by THZ treatment (Table S3C). These results
clearly show that the Mtb s
B regulon, which is activated by
treatment with SDS or diamide, via either s
E or s
H, is also
activated by treatment with THZ.
We then compared the transcriptome of Mtb treated with THZ
to that of Mtb treated with vancomycin (VAN) [38], and found a
very high degree of overlap between the two treatments. For this
purpose, data was obtained from Gene Expression Omnibus
(GEO) from the following replicate microarray experiments: 10 x
MIC VAN treated vs. untreated Mtb, at both 1 and 4 hrs. Raw
data was then filtered and analyzed in a manner comparable to
that described for our own data. We found that the expression of
160 genes was significantly induced in Mtb following VAN
treatment at both time points. 37 out of the 100 strongly co-
expressed members of the s
B regulon were present in this cluster
of 160 genes. Interestingly, the expression of 32 out of these 37
genes was also induced by THZ (Table S3D). These results show
that both VAN and THZ exert similar effects on Mtb.
Quantitative PCR based confirmation of array data
We performed quantitative real-time RT-PCR to confirm the
results of the whole-genome transcriptome response of Mtb to
THZ treatment. At each of the time-points at which RNA was
obtained for microarray experiments, we quantified the expres-
sion of at least one transcript. For this purpose, independent
triplicate experiments were performed and RNA isolated. RT-
PCR confirmed the induction of the Rv3160c, Rv3161c at 1 h;
Rv3614c, Rv3615c, Rv3616c (data not shown) at 4 h and
Rv2710, Rv2745c, Rv3065c at all time points in response to the
1x and 4x MIC THZ treatment. Rv0251c induced at all time
points in response to 4x MIC only (Table 1). Therefore, the
results obtained in our microarray experiments could be
independently validated. We also tested the changes in the
expression of three Mtb genes, s
B, Rv2745c and emrE, via RT-
PCR following treatment with 0.5x MIC for different periods of
time. However, at this concentration, treatment with THZ had
no impact on the expression of any of these three genes (not
shown).
Damage to Mtb cell-envelope by THZ
Due to the complete induction of the s
B operon, and the
recently documented role of this factor in protecting Mtb against
cell-envelope damage, we hypothesized that THZ may damage or
modulate Mtb cell-envelope. To address this question, we directly
analyzed the effect of THZ treatment on Mtb cell-envelope by
transmission electron microscopy (TEM). While Mtb not treated
with THZ appeared to have normal envelope morphology
(Figure 2A), those treated with either 1x (Figure 2B) or 4x
(Figure 2C) dose of THZ for 6 hr exhibited discernable changes in
the envelope morphology. A total of three fields (4–6 cells/field)
from each condition were examined. An average of ,33% (in 1x
MIC, 6 h) to ,66% (in 4x MIC, 24 h) of the examined cells
showed damage. Mtb treated with either a 1x (Figure 2D) or 4x
(Figure 2E) dose of THZ for 24 hr exhibited extensively more
damage to their cell-envelope. In fact, in these samples an
apparent loss of the integrity of the cell-envelope was visible. These
changes to the cell-envelope morphology increased both as a
function of time, as well as THZ concentration.
Role of the s
H/s
H/s
B network in protecting Mtb from the
stress generated by THZ
In Mtb, the alternate ECF sfactors s
H and s
E are intricately linked
to the principal minor sfactor s
B[28,29]. s
Hor s
Ecan independently
induce the expression of s
B. In the wake of a clear induction of the s
B-
expresson in Mtb by THZ, we hypothesized that a network of these
sfactors is important for protecting Mtb from the stress caused by THZ
mediated cell-envelope. We therefore studied the effect of THZ on the
viability of Mtb and its isogenic D–s
H and D–s
E deletion mutants
(Figure 3), as well as a strain where the expression of s
Bcould be condi-
tionally induced, under the control of the acetamidase promoter (Mtb:
s
B-KI). All four strains, (Mtb, Mtb:D–s
H, Mtb:D–s
E and Mtb: s
B-
KI) were either treated with 0.l x, 1x or 4x THZ or left untreated, and
their viability was observed over the course of the time. The Mtb:D–s
H
(Figure 3B) and the Mtb:D–s
E (Figure 3C) appeared to be significantly
more sensitive to a high-dose of THZ, relative to Mtb (Figure 3A).
However, the decrease in the viability of Mtb to a high level of THZ
treatment could be rescued in the Mtb:s
B-KI strain expressing high
levels of s
B (Figure 3D).
Modulation of intracellular redox potential by THZ
Previous studies have shown that THZ interacts with and
inhibits the activity of type-II NADH dehydrogenase, encoded by
Figure 2. TEM images of unexposed Mtb CDC 1551 control (A)
and following incubation for 6 hr (B, C) and 24 hr (D, E) with 1x
MIC (B, D)/4x MIC (C, E) THZ respectively. The arrows and lines
highlight areas of noticeable cell wall damage.
doi:10.1371/journal.pone.0010069.g002
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NAD(P)H to quinones, thus replenishing the NAD(P)
+ pool, and
regenerating intracellular potential. The increased expression of
ndh by THZ treatment in Mtb may be an attempt by the pathogen
to overcome the inhibition of this crucial enzymatic activity. We
therefore studied if treatment with THZ diminished the NADH/
NAD
+ ratio. Further, since the Mtb s
B (KI) strain appeared to
protect against THZ mediated stress, we studied if the NADH/
NAD
+ ratio would be protected in this strain. We observed a
significant decrease in the NADH/NAD
+ ratio in Mtb following
THZ treatment (Figure 4). While the decline in the intracellular
redox status was reflected in a decreased NADH/NAD
+ ratio in
both the strains, there was a significant (p=0.016) increase in this
ratio in the s
B (KI) strain, compared to Mtb CDC1551 (Figure 4).
These results clearly show that induction of s
B and presumably its
downstream regulon rescue the declining intracellular redox
potential in Mtb after THZ stress.
Discussion
MDR TB has necessitated the discovery of novel compounds
with activity against Mtb [1]. Ideally, these compounds would not
only have sterilizing activity against Mtb, but would also shorten
regimen times, and act through mechanisms different from those
employed by the existing frontline and secondary anti-TB drugs.
Phenothiazines such as chlorpromazine, thioridazine, prometha-
zine and methdilazine show promising in vitro activity against
clinical strains of Mtb regardless to their antibiotic susceptibility.
While THZ has some undesirable side-effects, its potential as an
antimicrobial, especially as an anti-mycobacterial can’t be ignored,
Figure 3. Thioridazine (THZ) inhibited the growth of Mtb CDC1551 (A), sigH mutant (B), sigE mutant (C) and s
B Knock-In (KI) mutant
(D) in a dose-dependent manner. *, p,0.05 **, p,0.01 ***, p,0.001 were considered to indicate 1 (0.1 x MIC), 10 (1 x MIC) and 40 (4 x MIC) mg/ml
THZ-treated groups where the OD values differed significantly compared to the untreated control group. The results represent mean 6 SD values
from three experiments. s
B over expression was induced by the addition of acetamide to 0.2%.
doi:10.1371/journal.pone.0010069.g003
Figure 4. Changes in redox status of NADH/NAD
+ during
treatment of Mtb CDC 1551 and s
B (KI) mutant with THZ. The
results represent mean 6 SD values from three experiments. s
B over
expression induced by the addition of acetamide to 0.2%.
doi:10.1371/journal.pone.0010069.g004
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burden. The side effects of THZ are generally very mild. While
severe side-effects have been reported, these are extremely rare
[10,11,17]. Therefore, we believe that THZ should be seriously
considered as an alternative for the therapy of MDR-TB infection.
Moreover, it is active against Mtb in a starved state and within
phagocytes [15]. It also exhibits synergism with RIF and STR [5].
It targets the type II NADH dehydrogenase and succinate
dehydrogenase and disrupts aerobic respiration under micro-
aerobic conditions [50]. THZ significantly reduces bacterial
burden in a mouse model of TB [19] and shows promising
activity in a mouse model of MDR-TB.
Our results show that treatment with THZ leads to rapid and
specific gene-expression responses in Mtb, particularly causing the
repression of many genes belonging to ‘‘Lipid Metabolism’’ and
‘‘Information Pathways’’, hence slowing down many important
biosynthetic pathways. We speculate that perhaps these energet-
ically expensive processes can’t be sustained by the pathogen in the
unfavorable environment due to the cell-envelope damage caused
by THZ. Additional experiments are however required to address
this hypothesis.
Mtb gene-expression response to THZ includes the putative
Rv3160c/Rv3161c operon, which is also induced by Tricosan,
SRI967 and SRI9190 [47]. The Rv3161c encoded dioxygenase
likely encodes an aromatic dioxygenase that could degrade the
halogenated diphenyl ether structure contained in these drugs.
Consistent with this assessment, the Rv3160c/Rv3161c operon is
not induced by treatment with SRI22, whose benzene ring is not
halogenated. The expression of the Rv3065 gene, which encodes a
multidrugs-transport integral membrane protein EmrE, and
another putative efflux pump gene, Rv1634, was also induced
following THZ treatment. THZ has been reported to act as an
efflux pump inhibitor in Mtb [10,11]. Our results prompt us to
speculate that the efflux pump inhibition caused by THZ leads to
the over-expression of the emrE and Rv1634 genes, as a potential
mechanism by the pathogen to resist this drug. In M. smegmatis,
deletion of the Rv3065 homolog causes increased susceptibility to
a number of drugs including ethidium bromide, acriflavin and
fluoroquinolones. THZ and related compounds are predicted to
act via the emrE-encoded efflux pump [10,11,51]. The induction of
ndh and efflux-pump (emrE) genes upon treatment of Mtb with
THZ confirms the data presented by Boshoff et al., [22], and
Amaral et al., [10,11], respectively.
Mtb genes involved in other regulatory circuits, with defined
roles in virulence and pathogenesis, such as the s
B regulon and the
Esx secretion pathway were also induced. The Mtb s
H [28–30],
s
E [35,52] and s
B [37] operons have been very well studied. A
growing body of evidence indicates that these operons are induced
in response to a pleothra of in-vitro conditions which mimic in-vivo
stress faced by the pathogen during the various stages of infection
and disease [28–30,35,37,41,53]. It appears that envelope damage
may serve as a key signal for Mtb to activate stress-defense
mechanisms, and numerous in-vitro conditions may be able to
replicate this. Damage to the envelope may inhibit specific targets,
e.g. ndh, thus causing changes to the intracellular redox potential.
Our results (Figure 4) indicate that the s
B regulon protects Mtb
from these changes. Our results, along with those of Fontan et al
[37], show that Mtb responses to oxidative and envelope-damage
stress converge at s
B and Rv2745c. Further research is therefore
warranted to study the role of these Mtb transcription factors.
The deployment of the s
B regulon appears to be an attempt by
the pathogen to protect against this stress. This has implications
for the in-vivo growth of Mtb, where it is likely to face similar stress.
The Rv2745c encoded transcription factor is a key member of the
Mtb s
H/s
E/s
B network, and its activity is induced in response to
various stress conditions (Mehra et al, unpublished work from our
group). It activates the expression of ATP-dependent Clp
proteolysis [30,54,55], and may also protect the Mtb envelope by
suppressing proton leakage [38]. The increase in the expression of
the Esx genes (Table S2A) either results from the damage to the
Mtb cell-envelope by THZ or may reflect increased secretion of
virulence related substrates by the pathogen. Rv1057, which
encodes a seven-bladed ß-propeller trans-membrane protein
[56,57], and which is induced in host cells during infection with
Mtb [56]; likely due to de-repression by TrcR, was also induced by
THZ. This gene is also a member of the s
E/s
B gene-expression
network and has been speculated to play a role in intraphagosomal
survival and metabolism of lipid substrates. The expression of the
lipL gene, which was induced in response to THZ, is also induced
by nutritional stress [58]. Envelope damage by THZ represses
metabolic biosynthesis (Figure 1). The expression of the lipL gene
may be required to degrade triacylglycerides as Mtb is forced to
obtain energy from alternative source [58].
This study identifies key Mtb gene-expression networks that are
impacted upon treatment with THZ - a novel, promising anti-
mycobacterial compound. Our work confirms the data presented
by Boshoff et al [22]. Our work also identifies one Mtb regulatory
network (s
B) involved in countering its effects, enhancing our
current understanding of the role played by this regulatory switch.
Our work lays the foundation of future interrogation of these
networks as potential drug-targets.
Supporting Information
Table S1 Primers used for the qRT-PCR.
Found at: doi:10.1371/journal.pone.0010069.s001 (0.16 MB PPT)
Table S2 Genes differentially regulated after treatment with
Thioridazine at 1XMIC/4XMIC at different time points
Found at: doi:10.1371/journal.pone.0010069.s002 (0.31 MB PPT)
Table S3 Induction of the Mtb s
B regulon by THZ. (A) s
B is up
regulated in THZ-induced Mtb. Further, 89 genes (out of top 100*)
that are very strongly co-expressed with s
B are also induced by
this treatment. (p,0.0001). *The gene expression correlation
values were computed as pair-wise Pearson correlations using the
microarray data sets from the Boshoff et al 2004 [22] study and
Dr. Schoolnik’s lab (unpublished data) and are imported from
TBDB. ‘‘Data was obtained from the NIAID BioHealthBase BRC
online through the web site at http://www.biohealthbase.org. (B)
Comparison between genes under s
B regulation during SDS stress
(Fontan et al 2009) [37] and THZ stress [this study]: 57 genes are
common among 73 (p,0.0001). (C) Comparison between genes
under s
B regulation during diamide stress (Fontan et al 2009) [37]
and THZ stress [this study]: 30 genes are common among
41(p,0.004). (D) Comparison between genes under s
B regulation
during VAN [38] and THZ treatment. 32 genes out of the 37 that
were induced by VAN in Mtb [38] were also induced by THZ
[this study]. Genes from the 100 member s
B- regulon that were
commonly regulated by THZ and the other listed treatments
(SDS, Diamide, VAN) are shown in bold. The genes not shown in
bold indicate oppositely regulated genes between THZ and the
other listed treatments.
Found at: doi:10.1371/journal.pone.0010069.s003 (0.29 MB
DOC)
Figure S1 A two-dimensional clustering heat map shows Mtb
genes that were expressed in a statistically significant manner in at
least one post-THZ treatment time-point (1, 2, 4, 6 hr) in either
the 1x or the 4x treatment experiment. The values are expressed in
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PLoS ONE | www.plosone.org 8 April 2010 | Volume 5 | Issue 4 | e10069base 2 logarithmic scale. The intensity of red color correlates with
a higher degree of expression in Mtb treated with THZ relative to
the control Mtb strain, while the intensity of the blue color
correlates with a lower degree of expression in Mtb treated with
THZ relative to the control Mtb strain. The genes with the highest
degree of blue and red color corresponds to a log2 fold change
value of 5.81 (i.e. a numeric fold change of .56 fold).
Found at: doi:10.1371/journal.pone.0010069.s004 (0.16 MB
PPT)
Figure S2 Venn diagrams. Venn diagrams show the degree of
association between the transcriptional induction of Mtb genes in
response to 1x (A) or 4x (B) THZ treatment at different time
points. Numbers at the intersection of more than one oval indicate
the number of genes overlapping between those time points.
Found at: doi:10.1371/journal.pone.0010069.s005 (0.11 MB PPT)
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